Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2018 May;4(1):43-45.
doi: 10.15420/cfr.2018:22:1.

Ambulatory Intra Aortic Balloon Pump in Advanced Heart Failure

Affiliations
Review

Ambulatory Intra Aortic Balloon Pump in Advanced Heart Failure

Syed Yaseen Naqvi et al. Card Fail Rev. 2018 May.

Abstract

Cardiac transplantation is the gold standard treatment for patients with advanced congestive heart failure that is refractory to maximal medical therapy. However, donor heart availability remains the major limiting factor, resulting in a large number of patients waiting long periods of time before transplantation. As a result, mechanical circulatory support devices have been increasingly used as a 'bridge' in order to sustain organ function and stabilise haemodynamics while patients remain on the transplant waiting list or undergo left ventricular assist device surgery. Intra aortic balloon pumps (IABP) are commonly used for temporary circulatory support in patients with advanced heart failure. IABP is traditionally placed percutaneously through the transfemoral artery approach. The major limitation with this approach is ambulatory restriction that can promote deconditioning, particularly in situations of prolonged circulatory support. A subclavian/axillary artery approach IABP insertion allows patients to be ambulatory during the pre-transplant period. In this review, we aim to summarise the physiology of IABP, the evidence for its use in advanced CHF and the efficacy and safety of subclavian artery IABP insertion.

Keywords: Intra aortic balloon pump; advanced heart failure; cardiac transplantation; left ventricular assist device; mechanical circulatory support; subclavian artery intra aortic balloon pump.

PubMed Disclaimer

Conflict of interest statement

Disclosure: The authors report no conflicts of interest.

Figures

Figure 1:
Figure 1:. Ambulatory Patient with Left Axillary Artery IABP, Inserted in the Cardiac Catheterisation Laboratory, Awaiting Heart Transplantation and Able to Participate in Physical Therapy

Similar articles

Cited by

References

    1. Bui AL, Horwich TB, Fonarow GC. Epidemiology and risk profile of heart failure. Nat Rev Cardiol. 2011;8:30–41. doi: 10.1038/nrcardio.2010.165. - DOI - PMC - PubMed
    1. Heidenreich PA, Albert NM, Allen LA et al. Forecasting the impact of heart failure in the United States: a policy statement from the American Heart Association. Circ Heart Fail. 2013;6:606–19. - PMC - PubMed
    1. Yancy CW, Jessup M, Bozkurt B et al. 2013 ACCF/AHA Guideline for the Management of Heart Failure. Circulation. 2013;128:e240. doi: 10.1161/CIR.0b013e31829e8776. - DOI - PubMed
    1. Norton C, Georgiopoulou VV, Kalogeropoulos AP, Butler J. Epidemiology and cost of advanced heart failure. Prog Cardiovasc Dis. 2011;54:78–85. doi: 10.1016/j.pcad.2011.04.002. - DOI - PubMed
    1. Yancy CW, Jessup M, Bozkurt B et al. 2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America. Circulation. 2017;136:e137–e61. doi: 10.1161/CIR.0000000000000509. - DOI - PubMed